In this report we discuss epidemiologic research designs which have been successful in illuminating etiologies of neurodevelopmental disorders, and the potential application of these designs in autism research. Neurodevelopmental disorders pose a special challenge to epidemiologic research, for several reasons. These include the need for prospective data on early prenatal exposures, the uncertainty of diagnoses, and the very large sample sizes required to examine gene-environment interactions in a prospective design. Nonetheless, several designs have proved adaptable for this purpose, of which we shall explore four: (a) pregnancy/birth cohort designs; (b) linked registry designs; (c) genetic high risk cohorts; (d) exposure based cohorts. To illustrate their potential we draw examples from research on another neurodevelopmental disorder, schizophrenia; we also use examples from autism research when available.
The first veritable birth cohort study was initiated in 1946 in the UK. 1 By the 1950s investigators in the United States were establishing pregnancy/birth cohorts in which mothers were recruited at the first prenatal visit rather than at the time of birth.
2 These pregnancy/birth cohort studies collected prenatal data not only by administering questionnaires and reviewing medical records, but also by obtaining and storing biological specimens (eg, maternal serum samples, placentas). In combination with neurodevelopmental assessments in childhood this innovation fundamentally altered the scope of hypotheses which could be addressed for neurodevelopmental disorders.
Many of the birth and pregnancy/birth cohorts have been followed up for schizophrenia and the results have had a profound effect on our understanding of this disorder. These follow-up studies have identified early childhood antecedents as well as risk factors for schizophrenia. [3] [4] Using the prenatal sera from pregnancy/birth cohorts, investigators are presently examining-among other things-the influence of infectious exposure and immunologic responses during gestation. Whereas birth cohorts have been used a great deal for schizophrenia research, we could find only one published example of birth cohorts being used to study etiologies of autism. In a nested case-control study based in a large pregnancy/birth cohort, Torrey et al classified 14 cases as having autism and investigated numerous potential risk factors, among which only bleeding during pregnancy was associated with autism. 5 The scarcity of applications in autism research is rather surprising, since the early age of onset of autism makes it feasible to investigate the disorder in pregnancy/birth cohorts with relatively short follow-up periods. Possibly the explanation is that autism was until recently thought to be extremely rare, and diagnoses were considered suspect. It seems likely that autism researchers will in future make far more use of the opportunities presented by large pregnancy/birth cohort studies.
In the post-World War II period several European countries have established registries including both birth registries and health outcomes registries. Often the health outcomes registries include neurodevelopmental disorders, for instance, in psychiatric registries or in disabilities registries. By linking birth and outcomes registries, it is possible to use routinely collected data on large populations to examine causes of neurodevelopmental disorders.
In registry studies, the limited information on individual biological parameters (eg, genes, prenatal infectious exposures), and the reliance on registry diagnoses, restrict the questions which can be effectively addressed and the precision of results. Notwithstanding these limitations, registry studies have yielded important findings in schizophrenia research, notably evidence for season of birth, urban birth, and low birth weight as risk factors for schizophrenia.
By contrast, registry studies on the causes of autism are few, perhaps because registry diagnoses for autism have been especially suspect. With the creation of dedicated autism registries and disabilities registries, these problems have been greatly reduced, and we believe that registry studies are poised to have a major impact on autism research. In some countries, an advanced system of registries has been developed appropriate for autism research, for example in Western Australia where linked registries include intellectual disability and autism outcomes, and pregnancy and birth data. 6 A recent report of Nelson et al demonstrates forefront uses of registry data. These authors reported an association of neurotrophic factors in newborn peripheral blood with risk of autism, identifying cases of autism in records of California state service agencies, and using stored newborn blood specimens to measure neurotrophic factors. 7 In genetic high risk cohorts, offspring of affected and unaffected individuals are followed from birth-or Epidemiologic approaches to neurodevelopmental disorders E Susser and M Bresnahan S3 soon thereafter-until they have passed through the age of risk of the disorder being investigated. The design exploits the higher recurrence of disorder in relatives, and the increased genetic contribution in offspring of affected parents. The approach can be used to identify early antecedents, to assess the risk associated with parental disorder, and to examine environmental risk factors that have an impact only in the presence of a genetic predisposition.
Genetic high risk studies of schizophrenia were initiated in the 1960s and have made important contributions. High risk studies have identified cognitive, behavioral, and neurobiological antecedents of this disorder. 8 Cannon et al used a high risk cohort to investigate environmental risk factors and found evidence that the effect of certain birth complications on ventricular enlargement is greater among individuals at higher levels of genetic risk for schizophrenia (indicated by two, one, or no affected parents). 9 In autism, genetic high risk studies follow the form of later born sibs of affected children, rather than offspring. 10 The recurrence risk of autism in siblings, estimated at 3-8%, is comparatively high. Because prospective information on children who go on to develop autism is scarce, either with respect to prenatal and infant biologic or developmental parameters, this design strategy may provide a unique opportunity to establish early markers of risk and early manifestations of autism. It may also provide the best opportunity to examine the impact of common environmental factors influencing risk of autism among those at genetic risk.
Exposure based high risk cohorts comprise individuals with a well defined prenatal exposure that might influence neurodevelopment. Cohorts have been established to capture the impact of epidemics, famine, teratogens, and other catastrophic occurrences. The design makes it possible to investigate factors that are too uncommon or too difficult to measure in general population pregnancy/birth cohorts. When the exposure leads to an increased risk of disorder, the cases in the cohort are enriched with a specific environmental etiology, and provide a good sample in which to identify genes that act in combination with environmental insult.
Exposure based cohorts have been used often in schizophrenia research during the past decade. An example is the Columbia Rubella Study cohort exposed to the 1964 rubella epidemic in New York City; offspring in this cohort had a far greater risk of schizoMolecular Psychiatry phrenia than unexposed cohorts of the same age.
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Another example is the Dutch Famine Study which compared cohorts exposed and unexposed in early gestation to the Dutch Hunger Winter of 1944-45; the cohort exposed to the famine in early gestation was at increased risk of schizophrenia. 12 The Rubella Study is especially pertinent here because it also provided key evidence for an environmental etiology of autism. Although the rubella cohort was small, the risk of autism in the cohort was extremely high. 13 The diagnosis of autism in this cohort, however, has been questioned based on the fact that the children with congenital rubella were multiply impaired. If the diagnoses were confirmed, genetic vulnerability in the context of viral exposure could be explored in this cohort.
We have described epidemiologic designs that have proved successful for other neurodevelopmental disorders such as schizophrenia but that have not as yet been widely applied in autism research. Although autism researchers perhaps have lagged a little up to now in the use of these designs, in the near future they will have the opportunity to surpass the achievements in fields such as schizophrenia research. New pregnancy/birth cohorts are being established in Denmark and Norway, and one is being considered for the United States, which will obtain prenatal biological specimens on very large populations. These present a golden opportunity for autism research, decades before their potential application in schizophrenia. 
